🇺🇸 FDA

Company profile · Sponsor

RedHill

RedHill Biopharma

RDHL · NYSE biotech TEL AVIV, L3, USA
Pipeline
14
Drugs
0
Patents
8

Quick answer

RedHill (RDHL) is a biotech company. headquartered in TEL AVIV, L3, USA. listed on NYSE. NovaPharmaNews links 14 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker RDHL
Exchange NYSE
Company type biotech
Headquarters TEL AVIV, L3, USA
SEC CIK 0001553846

Pipeline (14)

Search pipeline →

  1. Opaganib

    RedHill

    COVID-19

    phase 3 small molecule terminated

    2 trials

  2. Part A: Upamostat 200 mg

    RedHill

    Covid19

    phase 3 small molecule terminated

    1 trial

  3. RHB-102

    RedHill

    Gastroenteritis

    phase 3 small molecule completed

    1 trial

  4. RHB-104

    RedHill

    Crohn's Disease

    phase 3 small molecule completed

    1 trial

  5. RHB-104 (fixed-dose combination: 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine)

    RedHill

    Crohn Disease

    phase 3 small molecule completed

    1 trial

  6. RHB-105

    RedHill

    Helicobacter Pylori Infection

    phase 3 small molecule completed

    1 trial

  7. RHB-105

    RedHill

    Dyspepsia

    phase 3 small molecule completed

    1 trial

  8. RHB-204

    RedHill

    Pulmonary Mycobacterium Avium Complex Infection

    phase 3 small molecule terminated

    1 trial

  9. ABC294640

    RedHill

    Cholangiocarcinoma

    phase 2 small molecule completed

    1 trial

  10. BEKINDA

    RedHill

    Irritable Bowel Syndrome With Diarrhea

    phase 2 small molecule completed

    1 trial

  11. Opaganib

    RedHill

    Coronavirus Infections

    phase 2 small molecule completed

    1 trial

  12. RHB-104

    RedHill

    Relapsing Remitting Multiple Sclerosis

    phase 2 small molecule completed

    1 trial

  13. Rifamycin SV-MMX

    RedHill

    Traveler's Diarrhea

    phase 2 small molecule active

    2 trials

  14. Upamostat

    RedHill

    SARS-CoV-2

    phase 2 small molecule completed

    1 trial

Patents (8)

Search patents →

  1. US 12370206

    Therapy for inhibition of single-stranded RNA virus replication

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12115150

    Biomarkers of coronavirus pneumonia

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11931463

    All-in-one fixed-dose combination for treating Helicobacter pylori infection

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11918560

    Serine protease inhibitor for treating coronavirus infection

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11878011

    Method for eradicating Helicobacter pylori infection in patients regardless of body mass index

    Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11786541

    Inhibitor of sphingosine kinase 2 for treating Ebola

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11633385

    Combination compositions for treatment of cancer

    Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11590154

    Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is RedHill?

RedHill (RDHL) is a biotech company. headquartered in TEL AVIV, L3, USA. listed on NYSE. NovaPharmaNews links 14 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does RedHill sponsor?

We track 14 ClinicalTrials.gov-linked programs for RedHill, including Opaganib and 13 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does RedHill company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.